restructuring
CDER Employees Leave FDA in Droves Amid HHS Overhaul
CDER; FDA; HHS overhaul; employee resignations; layoffs; health policy; restructuring; Robert F. Kennedy Jr.
ADC Therapeutics Cuts 30% of Workforce, Closes UK R&D Site Amid Strategic Shift
ADC Therapeutics; layoffs; UK facility closure; biotech restructuring; R&D; antibody-drug conjugates; solid tumors; Zynlonta; preclinical programs
National Resilience Restructures Manufacturing Footprint, Closes 6 of 10 Plants
National Resilience; manufacturing; CDMO; restructuring; overcapacity; biotech
Recursion Pharmaceuticals Lays Off 20% of Staff Amid Pipeline Cutbacks
Recursion Pharmaceuticals; layoffs; pipeline cutbacks; biotech; workforce reduction; restructuring; rare diseases; oncology
Korro Bio Lays Off 20% of Workforce to Extend Runway for Genetic Medicine Trials and Novo Nordisk Partnership
Korro Bio; layoffs; biotech; genetic medicine; RNA editing; KRRO-110; Novo Nordisk; clinical trial funding; restructuring; AATD
Schrödinger Lays Off 60 Staffers Amid Economic Uncertainty
Schrödinger; layoffs; biotech; workforce reduction; economic conditions; cost cutting; restructuring
Prime Medicine CEO Exits Amidst Layoffs and Restructuring as Sole Clinical Gene Therapy Shelved
Prime Medicine; CEO exit; gene therapy; layoffs; restructuring; biotech; PM359; prime editing; clinical trial; pipeline pivot
Bayer Restructuring Cuts 2,000 Jobs, Thins Management Layers in 2025
Bayer; restructuring; job cuts; management layers; layoffs; Frankfurt plant closure; pharmaceutical industry
AI Drug Discovery Firm Insitro Lays Off 22% of Workforce Amid Ongoing Biotech Market Turmoil
Insitro, AI drug discovery, biotechnology layoffs, workforce reduction, tumultuous market, industry restructuring, biotech market trends, clinic readiness, cost-cutting, 2025 biotech layoffs
Takeda announces handful of pipeline cuts in effort to pivot resources
Takeda, pipeline, restructuring, Solid Neoplasm, pivot resources